Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cell Death & Disease|February 27, 2015
Mitochondrial DNA copy number is regulated by DNA methylation and demethylation of POLGA in stem and cancer cells and their differentiated progenyW Lee, J Johnson, D J Gough, et al.Cancer Research|July 17, 2001
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFRR B Luwor, T G Johns, C Murone, et al.Cancer Research|August 1, 1990
Pharmacokinetics, tissue distribution, and cell localization of [35S]methionine-labeled recombinant human and murine alpha interferons in miceT G Johns, J A Kerry, B A Veitch, et al.Cell Death Discovery|August 24, 2016
Mitochondrial DNA plasticity is an essential inducer of tumorigenesisW T Y Lee, J E Cain, A Cuddihy, et al.Cancer Research|July 17, 2001
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptorK Mishima, T G Johns, R B Luwor, et al.Oncogenesis|May 16, 2017
Cyclin-dependent kinase 7 is a therapeutic target in high-grade gliomaS A Greenall, Y C Lim, C B Mitchell, et al.British Journal of Cancer|July 3, 2008
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugsD M Ashley, C D Riffkin, M M Lovric, et al.Biochemical Pharmacology|March 9, 2006
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinaseA G Ellis, M M Doherty, F Walker, et al.British Journal of Cancer|March 17, 2005
Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFRC Panousis, V M Rayzman, T G Johns, et al.Pageof 3